119th Congress · introduced in the Senate · Jan 7, 2026
School Access to Naloxone Act of 2026
Official title from Congress.gov
Latest action (Mar 19, 2026): Committee on Health, Education, Labor, and Pensions. Hearings held.
View on Congress.govPolicy area: Health
Congressional Research Service summary, version: Introduced in Senate (Jan 7, 2026)
School Access to Naloxone Act of 2026
This bill authorizes grants for expanding access to drugs or devices to treat opioid overdoses (e.g., naloxone) in elementary and secondary schools.
The Department of Health and Human Services may award the grants to states, Indian tribes, and localities. To receive a grant, recipients must certify that schools in their jurisdictions will stock the drugs and devices and have trained staff on premises during operating hours to administer them.
Additionally, the attorney general of the recipient's state must certify that trained staff are covered by state civil liability protections for individuals who administer aid in an emergency (commonly known as Good Samaritan laws).
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Committee on Health, Education, Labor, and Pensions. Hearings held.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Actions from Congress.gov, newest first.
Drug therapy · Drug, alcohol, tobacco use · Education programs funding · Elementary and secondary education · Health technology, devices, supplies · School administration
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
No matching lobbying reports found within coverage